Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Graft Polymer (UK) PLC ( (GB:SVNS) ) has issued an update.
Solvonis Therapeutics PLC, a company involved in the healthcare sector, has announced a change in its voting rights structure following the issuance of new shares. The notification indicates that the total number of voting rights held by Nicholas Christian Paul Nelson has increased to 205,961,538, representing 3.49% of the total voting rights. This change is a result of the issuance of new shares by Solvonis Therapeutics, which has implications for the company’s shareholder structure and could impact its governance dynamics.
More about Graft Polymer (UK) PLC
Average Trading Volume: 10,789,241
Technical Sentiment Signal: Sell
Current Market Cap: £3.04M
Find detailed analytics on SVNS stock on TipRanks’ Stock Analysis page.